LivaNova rises following possible CMS reimbursement boost for vagus nerve stimulation [Seeking Alpha]
LivaNova PLC - Ordinary Shares (LIVN)
Last livanova plc - ordinary shares earnings: 4/29 06:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
livanova.com
Company Research
Source: Seeking Alpha
In a note, Baird's David Rescott wrote that he believes that the CMS Advisory Panel on Hospital Outpatient Payment voted in favor of the increase. If an increase is instituted, he added that it would allow LivaNova to leverage price and offer a better value proposition for VNS compared to deep brain stimulation. "It's still early to tell exactly how updated reimbursement would influence physicians; decisions and LIVN still has to contend with Italian litigation overhangs, but a meaningful increase to VNS reimbursement (if enacted in FY25) at face value should be a tailwind," Rescott wrote. The company's VNS system is used to treat drug-resistant epilepsy and difficult-to-treat depression. The stock traded higher by ~8% earlier in the trading session. Recommended For You More Trending News Recommended For You More Trending News About LIVN Stock Related Stocks Trending Analysis Trending News
Show less
Read more
Impact Snapshot
Event Time:
LIVN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LIVN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LIVN alerts
High impacting LivaNova PLC - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
LIVN
News
- LivaNova PLC (NASDAQ: LIVN) was upgraded by analysts at Baird R W from a "hold" rating to a "strong-buy" rating.MarketBeat
- LivaNova upgraded to Outperform at Baird, stock rises [Seeking Alpha]Seeking Alpha
- LivaNova PLC (NASDAQ: LIVN) was upgraded by analysts at Robert W. Baird from a "neutral" rating to an "outperform" rating. They now have a $66.00 price target on the stock, up previously from $55.00.MarketBeat
- CeriBell IPO Features Revenue Growth But High Operating Losses [Seeking Alpha]Seeking Alpha
- LivaNova PLC (NASDAQ: LIVN) had its "neutral" rating re-affirmed by analysts at Robert W. Baird. They now have a $55.00 price target on the stock.MarketBeat
LIVN
Earnings
- 7/31/24 - Beat
LIVN
Sec Filings
- 9/17/24 - Form 4
- 9/17/24 - Form 3/A
- 9/13/24 - Form 4
- LIVN's page on the SEC website